Skip to main content
. 2013 Nov 28;9(2):443–449. doi: 10.3892/mmr.2013.1834

Figure 3.

Figure 3

Staining of microvessels by anti-CD34 immunostaining (brownish staining) in (A) the control group and (B) the VPA-treated group. VPA, valproic acid.